Removing Incentives To Lower Drug Prices Isn’t Pharma ‘Reform’

Tuesday, January 14th 2025, 12:37:28 pm
article
Delinking legislation is a giveaway to the pharmaceutical industry that will prove costly to taxpayers and Part D enrollees.
Breaking
 This story isn't just my story; it's a symptom of a broken U.S. real estate market plagued by high interest rates, bloated prices, and criminally low supply.   Explore America's housing crisis throug...
U-Haul truck injures protesters at LA rally for freedom in Iran, highlighting ongoing struggles....
loading...